MELANI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 4.717
EU - Europa 2.786
AS - Asia 1.376
SA - Sud America 229
AF - Africa 43
OC - Oceania 38
Totale 9.189
Nazione #
US - Stati Uniti d'America 4.672
RU - Federazione Russa 1.068
PL - Polonia 555
SG - Singapore 440
CN - Cina 305
HK - Hong Kong 294
IE - Irlanda 244
SE - Svezia 227
IT - Italia 218
BR - Brasile 189
KR - Corea 137
DE - Germania 121
UA - Ucraina 110
FI - Finlandia 79
GB - Regno Unito 70
VN - Vietnam 60
AU - Australia 38
IN - India 37
FR - Francia 35
TR - Turchia 34
CA - Canada 29
CI - Costa d'Avorio 18
JO - Giordania 18
AT - Austria 15
AR - Argentina 13
BE - Belgio 11
NL - Olanda 11
ID - Indonesia 9
JP - Giappone 9
MX - Messico 9
PY - Paraguay 8
BD - Bangladesh 7
IQ - Iraq 7
CO - Colombia 6
CH - Svizzera 5
ES - Italia 5
SC - Seychelles 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
KE - Kenya 4
LT - Lituania 4
MA - Marocco 4
CR - Costa Rica 3
EG - Egitto 3
PE - Perù 3
PK - Pakistan 3
VE - Venezuela 3
ZA - Sudafrica 3
AL - Albania 2
JM - Giamaica 2
KG - Kirghizistan 2
SA - Arabia Saudita 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
MM - Myanmar 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 9.189
Città #
Santa Clara 1.157
Warsaw 553
Fairfield 406
Ashburn 323
Chandler 285
Singapore 285
Dublin 244
Hong Kong 239
Woodbridge 216
Wilmington 174
Cambridge 169
Seattle 166
Jacksonville 163
Houston 162
Beijing 142
Seoul 137
Ann Arbor 104
Dallas 98
Buffalo 81
Princeton 76
Altamura 74
Lawrence 71
Boston 55
Boardman 50
Florence 50
Los Angeles 50
Melbourne 38
Bremen 27
Hefei 27
San Diego 27
Kent 23
Mumbai 23
Paris 22
Moscow 21
Medford 19
Shanghai 19
Abidjan 18
Izmir 18
Munich 18
New York 16
Hanoi 15
Norwalk 15
Vienna 15
Dearborn 14
São Paulo 14
Ho Chi Minh City 13
Toronto 12
Brooklyn 11
Brussels 11
Clifton 11
Falls Church 11
Dong Ket 10
Hillsboro 10
Phoenix 10
Yubileyny 10
Falkenstein 9
London 9
The Dalles 9
Tokyo 9
Andover 8
Brasília 8
Jakarta 8
Milan 8
Redondo Beach 8
Auburn Hills 7
Helsinki 7
Montreal 6
Nanjing 6
Rome 6
Belo Horizonte 5
Bern 5
Denver 5
Frankfurt am Main 5
Mexico City 5
Saint Louis 5
Stockholm 5
West Jordan 5
Ankara 4
Asunción 4
Columbus 4
Genoa 4
Manchester 4
San Francisco 4
Turku 4
Verona 4
Betim 3
Biên Hòa 3
Calgary 3
Campinas 3
Casablanca 3
Chennai 3
Chicago 3
Fortaleza 3
Frankfurt Am Main 3
Guangzhou 3
Helena 3
Lima 3
Nairobi 3
Salerno 3
Santo André 3
Totale 6.253
Nome #
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia. 323
The Selective Antagonism of P2X7 and P2Y1 Receptors Prevents Synaptic Failure and Affects Cell Proliferation Induced by Oxygen and Glucose Deprivation in Rat Dentate Gyrus. 298
The neuron-astrocyte-microglia triad in CA3 after chronic cerebral hypoperfusion in the rat: Protective effect of dipyridamole 272
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia. 247
A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia 236
Role of adenosine in oligodendrocyte precursor maturation 227
The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: Protective effect of dipyridamole 225
Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection. 199
Adenosine and Oxygen/Glucose Deprivation in the Brain 191
Adenosine is present in rat brain synaptic vesicles. 185
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. 180
ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia 167
Purinergic signalling in brain ischemia 166
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. 165
Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study. 163
Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice 162
Adenosine A2A antagonists are protective in in vivo and in vitro models of brain ischemia. 161
Adenosine extracellular brain concentrations and role of A2A receptors in ischemia 159
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat 156
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats 153
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. 153
Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury 153
Adenosine A2A antagonists are protective in in vivo and in vitro models of brain ischemia. 152
Adenosine A2A receptor antagonism increases neuronal nitric oxide syntase expression in the striatum of huntington transgenic mice 147
P2X(7) receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat 144
Adenosine and Stroke 144
The selective A(2A) receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. 143
A2A receptors in neuroprotection of dopaminergic neurons. 137
Effects of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia 137
Effect of adenosine A2A receptor stimulation on GABA release from the striatum of young and aged rats in vivo 137
The protective effect of adenosine A2A receptor antagonism in cerebral ischemia 136
Selective adenosine A2A receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischemia 135
Role of adenosine A2A receptors in cerebral ischemia 133
Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. 132
Adenosine Receptors in Cerebral Ischemia 131
Adenosine as a biomarker of Huntington Disease 128
Effect of chronic administration of selective adenosine A2A receptor agonists and antagonists on cerebral injury evaluated up to seven days after focal ischemia in the rat 126
The role of ATP and adenosine in the brain under normoxic and ischemic conditions. 126
Time-course of the protective effect of selective adenosine A2A receptor agonists and antagonists after brain focal ischemia in the rat 125
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. 122
EFFECT OF N-METHYL-D-ASPARTATE ON MOTOR ACTIVITY AND IN VIVO ADENOSINE STRIATAL OUTFLOW IN THE RAT. 119
Selective adenosine A2A receptor agonists and antagonists protect at different times after brain focal ischemia in the rat 118
Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease. 116
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. 116
Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats 115
Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia 110
ADENOSINE AND MEMORY STORAGE: EFFECT OF A(1) AND A(2) RECEPTOR ANTAGONISTS. 109
A2A adenosine receptors inhibits glutamate release in vivo from the striatum of aging rats. 109
CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. 108
In vivo amino acid drelease from the striatum of aging rats: adenosine modulation. 107
The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord 107
Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake and freely moving rats after middle cerebral artery occlusion. Correlations with neurological deficit and histopathological damage. 104
Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. 100
Amino acids, adenosine choline extracellular levels as possible markers in human brain gliomas: an intraoperative microdialysis study. 93
Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: An intraoperative microdialysis study 92
Effect of A2A receptor antagonism on the histological damage, neurological deficit and striatal adenosine and aminoacid outflow following middle cerebral artery occlusion in the rat 88
Striatal outflow adenosine and amino acid following focal cerebral ischemia: correlation with neurological deficit and histological damage. 87
Intraoperative microdialysis in human brain gliomas: amino acids, adenosine and choline extracellular levels. 82
Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain 82
Excitatory aminoacid and GABA release from the rat striatum in vivo: effect of the selctive A2A adenosine receptor agonist CGS 21680. 79
Correlation between adenosine and amino acid outflow and neuropathological outcome in rat striatum following middle cerebral artery occlusion. 75
Selective adenosine A(2A) receptor antagonism reduces JNK MAPK activation in oligodendrocytes after cerebral ischaemia 75
The selective adenosine A2A antagonist SCH58261 is protective in a model of focal cerebral ischemia in the rat 75
Selective adenosine A2A receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischemia. 71
Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma 68
Effect of the selective adenosine A2A receptor antagonist, SCH 58261, in a model of permanent focal cerebral ischemia in the rat. 61
Effect of A2A receptor antagonism on glutamate outflow from the striatum of young and aged rats in vivo. 59
Sex-Dependent Long-Term Neurobehavioral Recovery in Experimental Neonatal Hypoxic-Ischemic Encephalopathy 9
Totale 9.310
Categoria #
all - tutte 25.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021412 0 0 0 0 0 91 27 68 48 100 31 47
2021/2022466 17 53 43 19 13 11 18 32 18 14 105 123
2022/20231.226 129 213 45 107 116 213 152 57 137 5 31 21
2023/2024367 20 46 74 18 21 26 11 120 4 6 16 5
2024/20252.984 101 286 206 457 927 490 47 166 106 67 83 48
2025/20261.469 264 405 227 141 424 8 0 0 0 0 0 0
Totale 9.310